|Table of Contents|

ARHGEF40 promotes colon cancer cell invasion through epithelial-mesenchymal transition

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2022 01
Page:
1-5
Research Field:
Publishing date:

Info

Title:
ARHGEF40 promotes colon cancer cell invasion through epithelial-mesenchymal transition
Author(s):
GU Jian; WANG Yihua; YU Juanhan
Department of Pathology，College of Basic Medical Sciences，China Medical University，Liaoning Shenyang 110001，China．
Keywords:
colon cancer; ARHGEF40; EMT; invasion
PACS:
R735.3+5
DOI:
10.3969/j.issn.1672-4992.2022.01.001
Abstract:
Objective:To investigate the effect of ARHGEF40 on the invasion of colon cancer cells and the expression of epithelial-mesenchymal transition marker proteins.To explore the mechanism via which ARHGEF40 regulates the invasion of colon cancer cells.Methods:Immunohistochemistry assay was performed to detect the expression of ARHGEF40 in colon cancer tissues and normal intestinal epithelial tissues.Transwell and Western blot assays were performed to determine the effect of ARHGEF40 overexpression and knockdown on colon cancer cells invasion and EMT marker protein expression.KEGG pathway enrichment analysis on the TCGA database was used to predict the possible mechanism of ARHGEF40 affecting the invasion of colon cells and EMT process.Results:Immunohistochemical analyses showed that the positive rate of ARHGEF40 in normal intestinal epithelial tissue was 22.2%(6/27),and in colon cancer tissue was 77.1%(37/48),which had a significant difference(P＜0.01).Western blot results revealed that ARHGEF40 was highly expressed in four colon cancer cell lines compared to normal intestinal epithelial cell line.Transwell assays indicated that overexpression of ARHGEF40 significantly promoted the invasion of colon cancer cells CL187 and SW620,where as knockdown of ARHGEF40 significantly inhibited the invasion of these two cells(P＜0.05).We also found that ARHGEF40 overexpression increased the expression of Snail,Slug,Vimentin，N-cadherin and decreased the expression of epithelioid marker protein E-cadherin in CL187 cell line.On the contrary,ARHGEF40 suppression downregulated the expression of Snail,Slug,Vimentin，N-cadherin and upregulated the expression of E-cadherin in SW620 cell line.Furthermore,enrichment analysis of KEGG signalling pathway showed that ARHGEF40 may activate TGF-β,WNT,NOTCH and MAPK signalling pathways in colon cancer.Conclusion:ARHGEF40 may promote the EMT and invasion of colon cancer cells by activating related signalling pathways.

References:

[1]MISIAKOS EP,KARIDIS NP,KOURAKLIS G.Current treatment for colorectal liver metastases［J］.World J Gastroenterol,2011,17：4067-4075.
[2]BAKIR B,CHIARELLA AM,PITARRESI JR,RUSTGI AK.EMT,MET plasticity,and tumor metastasis［J］.Trends in Cell Biology,2020,30：764-776.
[3]YOSHIDA T,OZAWA Y,KIMURA T,et al.Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition(EMT) to mesenchymal-epithelial transition(MET) states［J］.Br J Cancer,2014,110：1497-1505.
[4]王露瑶,吕娟,阮红杰.肿瘤干细胞的耐药机制研究进展［J］.山东医药,2019,59(36):111-114. WANG LY， LYU J，RUAN HJ.Research progress on the drug resistance mechanism of cancer stem cells［J］.Shandong Medical Journal,2019,59(36):111-114.
[5]ABIKO H,FUJIWARA S,OHASHI K,et al.Rho guanine nucleotide exchange factors involved in cyclic-stretch-induced reorientation of vascular endothelial cells［J］.J Cell Sci,2015,128：1683-1695.
[6]LI X,ZHU J,LIU Y,et al.MicroRNA-331-3p inhibits epithelial-mesenchymal transition by targeting ErbB2 and VAV2 through the Rac1/PAK1/β-catenin axis in non-small-cell lung cancer［J］.Cancer Sci,2019,110：1883-1896.
[7]DU J,ZHU Z,XU L,et al.ARHGEF11 promotes proliferation and epithelial-mesenchymal transition of hepatocellular carcinoma through activation of β-catenin pathway［J］.Aging(Albany NY),2020,12：20235-20253.
[8]JEMAL A,BRAY F,CENTER MM,et al.Global cancer statistics［J］.CA Cancer J Clin,2011,61：69-90.
[9]刘汉博.结直肠癌肝转移的治疗现状及研究进展［J］.现代诊断与治疗,2019,30(10):1599-1602. LIU HB.Current status and research progress in treatment of lliver metastasis from colorectal cancer［J］.Modern Diagnosis and Treatment,2019,30(10):1599-1602.
[10]BAE JS,LEE JW,YOO JE,et al.Genome-wide association study for the identification of novel genetic variants associated with the risk of neuroblastoma in Korean children［J］.Cancer Research and Treatment：Official Journal of Korean Cancer Association,2020,52：1251-1261.
[11]CAO J,YANG T,TANG D,et al.Increased expression of GEF-H1 promotes colon cancer progression by RhoA signaling［J］.Pathology,Research and Practice,2019,215：1012-1019.
[12]JIU Y,PERANEN J,SCHAIBLE N,et al.Vimentin intermediate filaments control actin stress fiber assembly through GEF-H1 and RhoA［J］.Journal of Cell Science,2017,130：892-902.
[13]WANG DW,TANG JY,ZHANG GQ,et al.ARHGEF10L expression regulates cell proliferation and migration in gastric tumorigenesis［J］.Biosci Biotechnol Biochem,2020,84：1362-1372.
[14]HUANG ZX,MAO XM,WU RF,et al.RhoA/ROCK pathway mediates the effect of oestrogen on regulating epithelial-mesenchymal transition and proliferation in endometriosis［J］.Journal of Cellular and Molecular Medicine,2020,24(18):10693-10704.
[15]MAKRODOULI E,OIKONOMOU E,KOC M,et al.BRAF and RAS oncogenes regulate Rho GTPase pathways to mediate migration and invasion properties in human colon cancer cells：a comparative study［J］.Mol Cancer,2011,10：118.
[16]PALLASCH FB,SCHUMACHER U.Angiotensin inhibition,TGF-β and EMT in cancer［J］.Cancers(Basel),2020,12(10):2785.
[17]LIU D,LIN L,WANG Y,et al.PNO1,which is negatively regulated by miR-340-5p,promotes lung adenocarcinoma progression through Notch signaling pathway［J］.Oncogenesis,2020,9：58.
[18]TANG Q,CHEN J,DI Z,et al.TM4SF1 promotes EMT and cancer stemness via the Wnt/β-catenin/SOX2 pathway in colorectal cancer［J］.Journal of Eperimental & Clinical Cancer Research,2020,39：232.
[19]HUANG L,CHEN S,FAN H,et al.GINS2 promotes EMT in pancreatic cancer viaspecifically stimulating ERK/MAPK signaling［J/OL］.Cancer Genetherapy,［2020-08-03］.https://pubmed.ncbi.nlm.nih.gov/32747685.DOI：10.1038/s41417-020-0206-7.

Memo

Memo:
辽宁省自然科学基金（编号：20170541007）
Last Update: 2021-12-02